Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Trichotillomania is a disorder where people compulsively pull out their hair, treated with drugs and behavior therapy.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Understanding gene expression in hair follicles can reveal insights into hair growth and disorders.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Some vitamins and minerals like vitamin D and iron can help with certain types of hair loss, but more research is needed for others.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Fullerenes show potential in skin care but need more safety research.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Human beard hair medulla contains a unique and complex mix of keratins not found in other human tissues.

Inherited ichthyoses cause widespread skin scaling and thickening due to gene mutations.

Hair shedding is an active process that could be targeted to treat hair loss.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

The conclusion is that Fgf18 and Tgf-ß signaling could be targeted for hair loss treatments.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

New treatments for acne scars are safer and more effective because we understand the causes better.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.